Double Blow: Roche Drugs for Breast Cancer and Alzheimer's Fail in Trials Swiss drug company Roche suffers a double blow with disappointing results of its two studies involving treatments for Alzheimer's disease and HER2 positive breast cancer. Shares of the company dropped following its announcement. by Rhodi Lee